Clinical Trials Directory

Trials / Conditions / Gastric Cancer Stage IV

Gastric Cancer Stage IV

17 registered clinical trials studyying Gastric Cancer Stage IV — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingConversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
NCT07241715
National University Hospital, SingaporePhase 2 / Phase 3
RecruitingSystemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for
NCT06519591
Ruijin HospitalPhase 2
CompletedStomach Cancer Exosome-based Detection
NCT06342427
City of Hope Medical Center—
RecruitingPhase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
NCT05319639
Fujian Cancer HospitalPhase 1 / Phase 2
UnknownPredictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.
NCT05301465
University of Pisa—
RecruitingPembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer
NCT04592211
Yonsei UniversityPhase 1 / Phase 2
UnknownEfficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric
NCT05204173
Ruijin HospitalPhase 2
UnknownTislelizumab Combined With Chemotherapy in First-line Treatment of AGC
NCT06034964
Cancer Institute and Hospital, Chinese Academy of Medical Sciences—
UnknownEfficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric
NCT04563975
Tao ZhangPhase 2
TerminatedTrastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC
NCT04168931
AC Camargo Cancer CenterPhase 2
UnknownConversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer
NCT04267549
Tianjin Medical University Cancer Institute and HospitalPhase 2
CompletedIntraperitoneal Paclitaxel Plus Systemic mFOLFOX6
NCT03618758
Seoul National University Bundang HospitalPhase 1 / Phase 2
CompletedPD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.
NCT03755440
Sun Yat-sen UniversityPhase 2
CompletedTo Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumo
NCT03159585
Zhujiang HospitalPhase 1
UnknownMaintenance Treatment With S-1 in Gastric Cancer Patients
NCT03701373
Sun Yat-sen UniversityPhase 2
CompletedReal-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer
NCT06666582
Hellenic Cooperative Oncology Group—
CompletedConversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer
NCT07009600
Samsung Medical Center—